165 related articles for article (PubMed ID: 6970645)
41. Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids.
Chesney RW; Mazess RB; Hamstra AJ; DeLuca HF; O'Reagan S
Lancet; 1978 Nov; 2(8100):1123-5. PubMed ID: 82684
[TBL] [Abstract][Full Text] [Related]
42. Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis.
Lawoyin S; Zerwekh JE; Glass K; Pak CY
J Clin Endocrinol Metab; 1980 Mar; 50(3):593-6. PubMed ID: 6965678
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and metabolic clearance of 1,25-dihydroxyvitamin D as determinants of serum concentrations: a comparison of two methods.
Maierhofer WJ; Gray RW; Adams ND; Smith GA; Lemann J
J Clin Endocrinol Metab; 1981 Sep; 53(3):472-5. PubMed ID: 6897931
[TBL] [Abstract][Full Text] [Related]
44. Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3.
Marx SJ; Swart EG; Hamstra AJ; DeLuca HF
J Clin Endocrinol Metab; 1980 Nov; 51(5):1138-42. PubMed ID: 6893458
[TBL] [Abstract][Full Text] [Related]
45. [Measurements of plasma concentrations of active vitamin D metabolites in children: interest and limit (author's transl)].
Garabedian M; N'Guyen TM; Guillozo H; Grimberg R; Balsan S
Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():857-65. PubMed ID: 7036931
[TBL] [Abstract][Full Text] [Related]
46. Effect of vitamin D2 on the assay of 24,25-dihydroxyvitamin D3 in man.
Taylor CM; Wallace JE; Cundy T; Kanis JA
Miner Electrolyte Metab; 1982 Jan; 7(1):15-9. PubMed ID: 6984878
[TBL] [Abstract][Full Text] [Related]
47. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
Moosgaard B; Vestergaard P; Heickendorff L; Mosekilde L
Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
[TBL] [Abstract][Full Text] [Related]
48. Vitamin D and its metabolites--supply of patients with various endocrine disorders and comparison of analytical methods.
Vosatkova M; Hoskovcova P; Bilek R
Endocr Regul; 2007 Mar; 41(1):19-28. PubMed ID: 17437341
[TBL] [Abstract][Full Text] [Related]
49. A seasonal difference in serum 25-hydroxyvitamin D3 in a Finnish population.
Savolainen K; Mäenpää PH; Alhava EM; Kettunen K
Med Biol; 1980 Feb; 58(1):49-52. PubMed ID: 7382580
[TBL] [Abstract][Full Text] [Related]
50. Serum concentrations of 24,25(OH)2D in uremic children: a reflection of renal function.
Weisman Y; Lum GM; Reiter EO; Gilboa N; Knox GF; Root AW
J Pediatr; 1979 Feb; 94(2):190-3. PubMed ID: 762605
[TBL] [Abstract][Full Text] [Related]
51. Cholecalciferol metabolites in polycythemic newborns.
Alkalay A; Pomerance JJ; Prause J; Mogilner BM; Edelstein S
Isr J Med Sci; 1985 Feb; 21(2):95-7. PubMed ID: 2984145
[TBL] [Abstract][Full Text] [Related]
52. Simultaneous determination of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1,25-dihydroxyvitamin D in plasma or serum.
Jongen MJ; van der Vijgh WJ; Willems HJ; Netelenbos JC; Lips P
Clin Chem; 1981 Oct; 27(10):1757-60. PubMed ID: 6974618
[TBL] [Abstract][Full Text] [Related]
53. Measurement of circulating 1,25-dihydroxyvitamin D in man. Changes in serum concentrations during treatment with 1 alpha-hydroxycholecalciferol.
Lund B; Lund B; Sørensen OH
Acta Endocrinol (Copenh); 1979 Jun; 91(2):338-50. PubMed ID: 463450
[TBL] [Abstract][Full Text] [Related]
54. The determination of 24,25-dihydroxyvitamin D and 25,26-dihydroxyvitamin D in plasma from normal and nephrectomized man.
Horst RL; Shepard RM; Jorgensen NA; DeLuca HF
J Lab Clin Med; 1979 Feb; 93(2):277-85. PubMed ID: 570996
[No Abstract] [Full Text] [Related]
55. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism.
Stern PH; De Olazabal J; Bell NH
J Clin Invest; 1980 Oct; 66(4):852-5. PubMed ID: 7419722
[TBL] [Abstract][Full Text] [Related]
56. [Persistent nephrotic syndrome in a child: blood levels of 25 hydroxyvitamin D].
Bensman A; Milhaud G
Nouv Presse Med; 1979 Apr; 8(16):1351. PubMed ID: 90364
[No Abstract] [Full Text] [Related]
57. Competitive protein binding assay for 1,25-dihydroxy-vitamin D in human plasma.
Dokoh S; Morita R; Fukunaga M; Yamamoto I; Torizuka K
Endocrinol Jpn; 1978 Oct; 25(5):431-6. PubMed ID: 744168
[TBL] [Abstract][Full Text] [Related]
58. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure.
Ishimura E; Nishizawa Y; Inaba M; Matsumoto N; Emoto M; Kawagishi T; Shoji S; Okuno S; Kim M; Miki T; Morii H
Kidney Int; 1999 Mar; 55(3):1019-27. PubMed ID: 10027939
[TBL] [Abstract][Full Text] [Related]
59. Reduced serum levels of 1 alpha,25-dihydroxyvitamin D during long-term total parenteral nutrition.
Klein GL; Horst RL; Norman AW; Ament ME; Slatopolsky E; Coburn JW
Ann Intern Med; 1981 May; 94(5):638-43. PubMed ID: 6786151
[TBL] [Abstract][Full Text] [Related]
60. Vitamin D metabolites in childhood nephrotic syndrome.
Grymonprez A; Proesmans W; Van Dyck M; Jans I; Goos G; Bouillon R
Pediatr Nephrol; 1995 Jun; 9(3):278-81. PubMed ID: 7632510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
